Off-Label Drug Use and FDA Review of Supplemental Drug Applications
by United States Congress House Commi
2022
Creative Media Partners, LLC·2 editions
Loading Description
Tags
NewBookshelves
0 readersNo users with this book on their shelves. Maybe you could be the first.
Threads
0 discussionsQuotes
0 quotesReviews
0 reviewsNo reviews yet. Add your review.
Lists
0 listsNo lists containing this book.